Acadian Asset Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Buy |
563,380
+218,819
| +64% | +$1.5M | 0.01% | 647 |
|
|
2025
Q1 | $989K | Buy |
344,561
+308,854
| +865% | +$887K | ﹤0.01% | 939 |
|
|
2024
Q4 | $167K | Sell |
35,707
-153,254
| -81% | -$717K | ﹤0.01% | 1284 |
|
|
2024
Q3 | $674K | Buy |
+188,961
| New | +$674K | ﹤0.01% | 1014 |
|
|
2021
Q2 | – | Sell |
-3,471
| Closed | -$41K | – | 2070 |
|
|
2021
Q1 | $41K | Buy |
+3,471
| New | +$41K | ﹤0.01% | 1870 |
|
|
2020
Q4 | – | Sell |
-1,881
| Closed | -$15K | – | 2254 |
|
|
2020
Q3 | $15K | Buy |
+1,881
| New | +$15K | ﹤0.01% | 2105 |
|